0001179110-21-003876.txt : 20210330 0001179110-21-003876.hdr.sgml : 20210330 20210330170926 ACCESSION NUMBER: 0001179110-21-003876 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210224 FILED AS OF DATE: 20210330 DATE AS OF CHANGE: 20210330 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Schwartz Carl I. CENTRAL INDEX KEY: 0001573354 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-36790 FILM NUMBER: 21787665 MAIL ADDRESS: STREET 1: 20155 N.E. 38TH COURT, UNIT 3104 CITY: AVENTURA STATE: FL ZIP: 33180 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Predictive Oncology Inc. CENTRAL INDEX KEY: 0001446159 STANDARD INDUSTRIAL CLASSIFICATION: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842] IRS NUMBER: 331007393 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2915 COMMERS DRIVE, STREET 2: SUITE 900 CITY: EAGAN STATE: MN ZIP: 55121 BUSINESS PHONE: 651-389-4800 MAIL ADDRESS: STREET 1: 2915 COMMERS DRIVE, STREET 2: SUITE 900 CITY: EAGAN STATE: MN ZIP: 55121 FORMER COMPANY: FORMER CONFORMED NAME: Precision Therapeutics Inc. DATE OF NAME CHANGE: 20180314 FORMER COMPANY: FORMER CONFORMED NAME: Precision Therapeutic Inc. DATE OF NAME CHANGE: 20180208 FORMER COMPANY: FORMER CONFORMED NAME: Skyline Medical Inc. DATE OF NAME CHANGE: 20130807 4/A 1 edgar.xml FORM 4/A - X0306 4/A 2021-02-24 2021-03-12 1 0001446159 Predictive Oncology Inc. POAI 0001573354 Schwartz Carl I. 3750 LAS VEGAS BLVD. SOUTH APT. 4303 LAS VEGAS NV 89158 0 0 0 1 Former CEO Common Stock 2021-02-24 4 A 0 100401 1.43 A 1711742 D On April 21, 2020, the reporting person exchanged an outstanding promissory note of the issuer for shares of common stock at $1.43 per share pursuant to an exchange agreement. The parties subsequently discovered a calculation error under which an additional $143,574 in interest should have been included in the balance of the exchanged note as of April 21, 2020, and the additional shares reported herein were issued on account of such additional interest. This form is being amended to correct the transaction code to an "A" to reflect that the transaction between the Issuer and Officer (at the time) is exempt under Rule 16b-3(d). /s/ Carl I. Schwartz, DDS 2021-03-30